SCHEMBL24458095

SCHEMBL24458095

COc1c(C)cc(Cl)cc1CO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 1/20 0.42
SCN4A P35499 4/20 0.39
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP2C19 P33261 1/20 0.37
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
PDE5A O76074 1/20 0.35
PDE1A P54750 1/20 0.35
PDE1B Q01064 1/20 0.35
PDE3B Q13370 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12636264 0.82 DHFR (0.42) MAPTKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL6407105 0.82 KMT2A (0.61) MAPTKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL20362610 0.80 MAPT (0.47) MAPTKMT2APDE4APDE4BPDE4C
SCHEMBL19872533 0.79 MAPT (0.43) MAPTKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL4932262 0.79 KMT2A (0.46) MAPTKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL15054521 0.79 MAPT (0.43) MAPTKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL10863911 0.79 CYP3A4 (0.46) MAPTKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL12504651 0.79 SCN4A (0.44) MAPTKMT2ASCN4ASMN1; SMN2L3MBTL1
SCHEMBL10734341 0.78 MAPT (0.46) MAPTCYP1A2PDE4APDE4BPDE4C
SCHEMBL416315 0.78 GAA (0.55) KMT2ACYP1A2CYP2D6CYP2C9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109001-A1 GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC (US) 2022-05-27 WO disclosed